HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lenalidomide: a synthetic compound with an evolving role in cancer management.

Abstract
Lenalidomide is a functional and structural analogue of thalidomide with a relatively benign toxicity profile and pleiotropic anti-tumor activity, exhibiting anti-angiogenic and immunomodulatory effects. Lenalidomide has already been approved for the management of low or intermediate-1 risk myelodysplastic syndrome with chromosome 5q31 deletion and relapsed/refractory multiple myeloma in combination with dexamethasone. During the last five years, multiple clinical trials have been conducted to explore its potential efficacy in hematologic as well as in solid malignancies, revealing a significant benefit in clinical outcomes. This review outlines the mechanisms of action, the toxicity profile and the efficacy of lenalidomide, reviewing the current literature and focusing on the current status of the compound in cancer management. The determination of molecular biomarkers, predictive of clinical response to lenalidomide may reveal a more substantial role of this agent in the treatment of hematologic as well as solid malignancies.
AuthorsVassiliki Saloura, Petros D Grivas
JournalHematology (Amsterdam, Netherlands) (Hematology) Vol. 15 Issue 5 Pg. 318-31 (Oct 2010) ISSN: 1607-8454 [Electronic] England
PMID20863427 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Thalidomide
  • Dexamethasone
  • Lenalidomide
Topics
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Dexamethasone (administration & dosage)
  • Hematologic Diseases (drug therapy)
  • Humans
  • Lenalidomide
  • Multiple Myeloma (drug therapy)
  • Myelodysplastic Syndromes (drug therapy)
  • Neoplasms (drug therapy)
  • Thalidomide (administration & dosage, analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: